Agency urges researchers to make more use of yellow card dataBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39381.659688.DB (Published 01 November 2007) Cite this as: BMJ 2007;335:907
- Roger Dobson
Researchers are being urged to make more use of yellow card data on reported adverse reactions to drugs in the United Kingdom.
The call from the Medicines and Healthcare Products Regulatory Agency comes after the publication of the first annual report by its independent scientific advisory committee. The committee reviews the scientific merit of proposals for using data from the card scheme and the general practice research database in research.
“The potential of the data we hold for public health research is unparalleled, and I am delighted that the launch of this first report shows that this is increasingly recognised by researchers,” said …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial